Generics Co. Asks Fed. Circ. To Revive Fortican Claims
A generic-drug maker tried Monday to persuade the Federal Circuit to revive its failed counterclaims and bid for summary judgment in Unigene Laboratories Inc.'s suit alleging it infringed two patents for...To view the full article, register now.
Already a subscriber? Click here to view full article